Todd C Davis
CIK 1392029 · Chief Executive Officer · last filed 2026-04-01
Todd C Davis is a Chief Executive Officer who has filed 77 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for PTHS, was dated Apr 1, 2026. Across all open-market trades the lifetime net is −$5.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $92.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$92.77M
6
77
-$5.55M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTHS | Director | 1,520,778 | $27.50 | $41.82M | $0 | 2 | 2026-04-01 |
| LGND | Chief Executive Officer | 199,381 | $255.54 | $50.95M | -$5.35M | 49 | 2026-03-27 |
| PVLA | Director | — | $108.81 | — | $0 | 2 | 2025-06-11 |
| Pelthos Therapeutics Inc. (CHRO) Delisted | Director | 29,167 | $13.50 | $393.8K | $0 | 3 | 2024-11-15 |
| Vaxart, Inc. (VXRT) Delisted | Director | 125,905 | $0.32 | $40.3K | -$196.5K | 7 | 2022-08-08 |
| ARTES MEDICAL INC (ARTE) Delisted | Director | — | $10.73 | — | $0 | 3 | 2008-02-15 |
Recent Filings
77 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-01 | PTHS | Grant (A) | +36,969 | $0 | EDGAR |
| 2026-03-27 | LGND | Grant (A) | +10,495 | $0 | EDGAR |
| 2026-02-18 | LGND | Mixed | +27,549 | -$6.04M | EDGAR |
| 2025-12-08 | LGND | Gift (G) | −130 | $0 | EDGAR |
| 2025-07-07 | PTHS | Grant (A) | — | $0 | EDGAR |
| 2025-07-03 | — | Mixed | +1,500,000 | $15.00M | |
| 2025-07-02 | LGND | Other (J) | +233 | $21.2K | EDGAR |
| 2025-06-11 | PVLA | Grant (A) | — | $0 | EDGAR |
| 2025-05-13 | LGND | Buy (P) | +9,510 | $1.00M | EDGAR |
| 2025-03-06 | LGND | Grant (A) | +21,382 | $0 | EDGAR |